2017 Project Fund Program


The 2017 round of the MTPConnect Project Fund Program provided $7.38 million of funding for 20 national projects in the medtech, biotech and pharmaceutical (MTP) sector, that could leverage over $15.2 million in industry partner funds. The selected projects are set to deliver results on a national scale, have sector-wide impact, and are aligned with MTPConnect’s Sector Growth Priorities as defined in our 10-year Sector Competitiveness Plan.


2017 Project Snapshot

Project Title Description Lead Participant Other Participants MTPConnect Grant
Pan-Asia Regenerative Medicine (PARMA) Program Aiming to develop and implement a global framework to identify and match research, marketing and investment opportunities in regenerative medicine, leveraging the pre-existing relationships between the sectors in South Korea, Japan and Australia to test and develop PARMA before expanding to other countries. AusBiotech Asialink Business, Global Stem Cell and Regenerative Medicine Acceleration Centre (GSRAC), FIRM, CCRM Australia, Regeneus Ltd $200,000
Establishment of an MTP competency based, manufacturing skills development facility/training hub and early stage clinical trial manufacturing facility Establishment of a manufacturing and hands-on training facility to facilitate the translation of innovative pharmaceutical products for early stage human clinical trials by providing the necessary infrastructure, equipment and manufacturing systems. Translational Research Institute (TRI) TRI, PharmOut, Eurofins AMS $500,000
Australia-China Life Sciences Partnership Program To increase awareness and opportunities for communication, collaboration and commercialisation between the life sciences sector in Australia and China. It will also deliver high quality, collaborative research and industry projects as well as valuable data analytics on commercial engagement between the two countries. AusBiotech Asialink Business, China BlueSky Partners, FB Rice, KPMG, King & Wood Mallesons, Therapeutic Innovation Australia $170,000
AMMRF Technical Voucher Fund The scheme will fund vouchers to support MedTech R&D by providing easy and discounted access to Australian Microscopy and Microanalysis Research Facility (AMMRF) microscopy services, reducing existing barriers to use. University of Sydney University of Queensland, University of Western Australia, University of New South Wales, University of Adelaide, University of South Australia, Australian National University, Flinders University $250,000
Ab-initio pharma | Formulation and GMP product manufacturing services for clinical trials in Australia Establishment of a Ab-initio, a unique pharmaceutical product design, formulation, manufacturing and training facility that provides cost effective solutions for small-to-medium enterprises, academics, clinicians and larger pharma for early phase clinical trials in Australia. University of Sydney University of Sydney, Sydney Local Health District NSW, ARCS Australia $500,000
Clinical Trial Assist - facilitating clinical trial recruitment in general practice To provide funds for a feasibility study to develop and evaluate a model to support clinical trial feasibility assessment and patient recruitment in Australia by utilising a large general practice network and data set. VentureWise Pty Ltd NPS Medicinewise Group, Prospection, The George Institute $150,000
CliniTrial Refer Australia integrated platform development Developing a new IT platform connecting doctors and patients to recruiting trials across research networks. This project will integrate 19 ClinTrial Refer derivative apps, create one combined database, new search functions, enable electronic referrals, link to ANZCTR and build a national solution to trials recruitment. South Eastern Sydney Local Health District (SESLHD) and Sydney Local Health District (SLHD) University of Sydney, Linear, SESLHD, SLHD, Australian Clinical Trials Alliance (ACTA), Australian New Zealand Clinical Trials Registry (ANZCTR), ClinicalTrials Connect, Research4Me, Amgen, Canteen $375,000
The Bridge Tech Program Providing mid-career, senior entrepreneurs and scientists with access to relevant, specific commercialisation training, medtech conferences and internships. The program will be delivered by companies, universities and industry operating in the sector through online mediums, residential training, and networking events. Queensland University of Technology QUT, Siemens Healthcare, Stryker, Cook Medical, Hydrix, IDE Group, Flinders University, Magnetica, Cicada Innovations, Ellume, The Actuator, Immunexpress $300,000
Certara-Monash University Industry Fellowship Program The Certara-Monash University Industry Fellowship Program will identify and develop the next generation of industry-experienced drug development pharmaceutical scientists with real world drug development experience through training in clinical pharmacology, pharmacometrics and regulatory science, who will help shape the future of the biotech and pharmaceutical industry. Certara Australia Pty Ltd Monash University $750,000
Building clinical trial capability and capacity to grow the MTP sector The MTP clinical trials sector is constrained in growth through lack of appropriately skilled and experienced workforce participants. This project aims to train and connect graduates with MTP clinical trial companies to equip them with job ready skills to meet this MTP sector gap. ARCS Australia Ltd

ARCS Australia Ltd, Clinical Network Services (CNS) Pty Ltd, George Clinical Pty Ltd, Monash University, Novotech Ltd, OnQ Recruitment Pty Ltd, Pharma to Market Pty Ltd, PPD Australia Pty Ltd, QuintilesIMS Pty Ltd, Seerpharma Pty Ltd, SPHERE, St Vincent’s Hospital, Melbourne, University of the Sunshine Coast, University of Sydney, UNSW, Sydney

$250,000
Enabling Precision Cancer Clinical Trials: A molecular profiling platform for the Australian clinical trials industry This project will enable Australian SMEs to enhance clinical trials through access to the Garvan Institute’s molecular profiling platform; including a clinically-accredited tumour genomic test, an analysis platform, and patient-matching capabilities to facilitate recruitment and optimise treatment. The Garvan Institute of Medical Research NHMRC Clinical Trials Centre, NSW Early phase Clinical Trials Alliance (NECTA), Genome.One , Linear Clinical Trials, Illumina Technology $400,000
Training Programs for the Biologics and Biomedical-based Industry Sector The design and creation of training programs for companies associated with the R&D and advanced manufacturing of biologic medicines and biomedical sciences. The training program will improve the knowledge and skills base necessary for advancement of Australian industry in this sector. Australian Institute for Bioengineering and Nanotechnology, University of Queensland (QUT)
Abbvie, Australian Red Cross Blood Service (ARCBS), ACYTE Biotech, Avipep, CSL Ltd, LuinaBio, Patheon Biologics
$110,000
The Healthy Living Design Hub

Funding to work with medtech companies to create customer-focused health solutions, offering real life testing for new health technology products and services. Programs focus on user-centered interactive design, translating ideas from concept to prototype with clear paths to market and long-term product development planning.

Swinburne University of Technology Swinburne University of Technology, Central Queensland University (CQU), Cairns Taipans (NBL), CSIRO, Thermal Hyperformance Pty Ltd, Richmond Football Club Ltd, Planet Innovation Pty Ltd and a major transport operator $500,000
Installation of robotic sterile finished product clinical trial manufacturing capability Support for Pharmaceutical Packaging Professionals to add a fully robotic, sterile vial-filling line to manufacture Phase II and III products, to their facility, which can then be used by Australian companies to locally produce product for clinical trials. Pharmaceutical Packaging Professionals Pty Ltd Clinical Network Services $500,000
The Bioprint Facility for Translational Science and Medicine in the MTP Sector This project will allow SMEs to engage with the BioPrint facility and technical experts at the University of Wollongong to establish a world first facility to enable the development of bioinks and customised bioprinting systems for targeted clinical applications. University of Wollongong SMR Automotive Australia Pty Ltd, Sydney Eye Bank, St Vincents Hospital Melbourne, Lincoln Consulting Group $400,000
Accelerating precision therapies through digital infrastructure for adaptive trials and trial-ready cohort studies The project is a feasibility study for the development of national digital infrastructure to support adaptive clinical trials and ‘trial-ready’ natural history cohort studies for a number of rare diseases. The digital study will improve efficiencies in drug evaluation through trial enrolment, data collection, and enabling analysis for novel trial designs. Murdoch University Telethon Kids Institute, University of Western Australia, Linear Clinical Research, Barwon Health, St John of God Subiaco, Foundation for Angleman Syndrome Therapeutics Australia (FAST), MNDi Foundation, Princess Margaret Hospital, Cystic Fibrosis $200,000
National MTP+D Live Showcase: Searchable, trackable, public pipelines for medtech, pharmaceutical and digital health innovations Cataloguing and tracking of publicly accessible, searchable online showcase of the MTPD innovations under development in Australia. Investors, practitioners and consumers can follow the progress of any innovation as the showcase is updated in real time using a humanized machine learning system. Visit the website if you are interested in being involved. Health Innovate Pty Ltd Health Horizon, Hospital and Health Services IP Ltd, Novartis Pharmaceuticals Australia, ANDHealth, Health Informatics Society of Australia (HISA), Medical Technology Association of Australia (MTAA), Medical Software Industry Association (MSIA), Better Health, Healthcare and Treatment Global Impact Cluster, (University of Newcastle) Melbourne Academic Centre for Health (MACH), QUT Biomedical Industry Group $100,000
A cloud-based AI digital health platform (hospital 4.0) applied to nationwide cardiovascular clinical decision support Implementation of an Artificial Intelligence digital health platform to eliminate avoidable/preventable errors in health care services by automating best practice clinical guidelines and delivering real time guidance to clinical decision makers, with initial focus on cardiovascular services in rural/remote SA. Integrated Cardiovascular Clinical Network (iICCnet), CHSA Alcidion Corp. Adelaide, AstraZeneca Australia Macquarie Park, Cardihab Pty Ltd Fortitude Valley, Chamonix Health Solutions Adelaide, Medical Communications Associates Pty Ltd, Medi‐Map Ltd Christchurch, SysLinx Pty Ltd Adelaide, Flinders University Adelaide, University of South Australia $340,000
Operationalise the Centre for Commercialisation for Regenetive Medicine Australia Accelerating the commercialisation of Australian regenerative medicine therapies and related products, building on the 2016 Project Fund Program supported development of CCRM Australia as a hub, via training; fostering increased collaboration between industry and academia, both locally and globally; and nurturing local regenerative medicine companies. Monash University Australian Regenerative Medicine Institute (ARMI), CCRM (Canada), Bioplatforms Australia (BPA), Cell Therapy Manufacturing CRC, Australian National Fabrication Facility (ANFF), ReNerve Pty Ltd, Cynata Therapeutics Ltd, Regeneus Ltd, Australian Red Cross Blood Service, Therapeutic Innovation Australia (TIA), Industry Mentoring Network in STEM (IMNIS), Australian Institute for Musculoskeletal Science (AIMSS), Scinogy Pty Ltd, Bioforum (CCRM Israel), Ear Science Institute, CSIRO, Cell Therapies Pty Ltd, St Vincent’s Institute of Medical Research, AusBiotech Pty Ltd. $390,000
Accelerating Australia - Stage 2 Facilitating translation of biomedical research through entrepreneurial experience courses and support services, to improve collaborating across sectors, organisations and disciplines to identify promising biomedical products and assist in bringing them to production. Centre for Entrepreneurial Research and Innovation (CERI) The University of Western Australia, Monash University, University of Adelaide, The University of Melbourne, University of Technology Sydney, University of Sydney, SPARK CoLab, Orthocell, Avita Medical Ltd, Proteomics International, Murdoch University, Curtin University, Edith Cowan University, Macquarie University, Harry Perkins Institute of Medical Research, Telethon Kids Institute, Lions Eye Institute, Ear Science Institute Australia, Perron Institute for Neurological and Translational Science Australia, St John of God Healthcare, SPARK Global USA, Linear Clinical Research, Cook Medical, Translational Research Institute, Illawarra Health and Medical Research Institute, University of Wollongong, RMIT, University of Newcastle, Centre for Nanoscale BioPhotonics, ASCEPT, Knowledge Translation Australia. $1,000,000